Abstract
IntroductionIt is common for patients to switch between several healthcare providers. In this context, the long-term follow-up of medical conditions based on laboratory test results obtained from different laboratories is a challenge. The measurement uncertainty in an inter-laboratory context should also be considered in data mining research based on routine results from randomly selected laboratories. As a proof-of-concept study, we aimed at estimating the inter-laboratory reference change value (IL-RCV) for exemplary analytes from publicly available data on external quality assessment (EQA) and biological variation.Materials and methodsExternal quality assessment data of the Reference Institute for Bioanalytics (RfB, Bonn, Germany) for serum creatinine, calcium, aldosterone, PSA, and of whole blood HbA1c from campaigns sent out in 2019 were analysed. The median CVs of all EQA participants were calculated based on 8 samples from 4 EQA campaigns per analyte. Using intra-individual biological variation data from the EFLM database, positive and negative IL-RCV were estimated with a formula based on log transformation under the assumption that the analytes under examination have a skewed distribution.ResultsWe estimated IL-RCVs for all exemplary analytes, ranging from 13.3% to 203% for the positive IL-RCV and - 11.8% to - 67.0% for the negative IL-RCV (serum calcium - serum aldosterone), respectively.ConclusionExternal quality assessment data together with data on the biological variation – both freely available – allow the estimation of inter-laboratory RCVs. These differ substantially between different analytes and can help to assess the boundaries of interoperability in laboratory medicine.
Highlights
It is common for patients to switch between several healthcare providers
Using intra-individual biological variation data from the European Federation of Laboratory Medicine (EFLM) database, positive and negative inter-laboratory reference change value (IL-Reference change values (RCV)) were estimated with a formula based on log transformation under the assumption that the analytes under examination have a skewed distribution
Data sets were evaluated for the five analytes: serum calcium, creatinine, aldosterone, prostate-specific antigen (PSA), and whole blood haemoglobin A1c (HbA1c)
Summary
It is common for patients to switch between several healthcare providers In this context, the long-term follow-up of medical conditions based on laboratory test results obtained from different laboratories is a challenge. A major objective of laboratory medicine is standardization, which is intended to enable the interoperability of results from different test sites [1,2] This is essential for both the development and application of clinical algorithms with decision limits based on laboratory values and for the long-term follow-up of patients with chronic diseases. Discrepancies in values due to insufficient standardization can in principle be compensated by the determination of method-specific reference values; for scientific applications, the evaluation can for example, be carried out as x-fold of a certain reference range value This is currently not practiced for essential laboratory analytes.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have